Clinical Trial Update: Trichuris Suis Ova (TSO)in Recurrent Remittent Multiple Sclerosis and Clinically Isolated Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Trichuris suis ova (TSO) for relapsing-remitting multiple sclerosis and clinically isolated syndrome has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clinically Isolated Syndrome
• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Trichuris suis ova (TSO) (Trichuris suis ova)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Multiple Sclerosis | Phase 2 | Status: TERMINATED